Drupal.behaviors.print = function(context) {window.print();window.close();}>
In Vivo Study Suggests Potential Efficacy of Proteome Sciences' Anti-Alzheimer's CK1D Inhibitors
January 04, 2013
In Vivo Study Suggests Potential Efficacy of Proteome Sciences' Anti-Alzheimer's CK1D Inhibitors
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Study Suggests Flaws in Standard Cognitive Alzheimer's Test Could Undermine Drug, Biomarker Research
December 21, 2012 / ProteoMonitor
Multi-Center, Multi-Cohort Alzheimer's Study Identifies Four Potential Protein Markers
August 17, 2012 / ProteoMonitor
Proteome Sciences Hits Milestone in Alzheimer's Drug Development Program
August 10, 2012 / ProteoMonitor
BU Team IDs RNA-Binding Proteins as Potential Alzheimer's Biomarkers
June 22, 2012 / ProteoMonitor
Proteome Sciences Completes 1,000-Patient Validation Study of Alzheimer's Plasma Protein Markers
March 30, 2012 / ProteoMonitor